## Abstract There are little data on the putative association between factors in the metabolic syndrome (MetS) and risk of bladder cancer. In the Metabolic Syndrome and Cancer project (Me‐Can), measurements of height, weight, blood pressure and circulating levels of glucose, cholesterol, and trigly
Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can)
✍ Scribed by Tanja Stocks; Annekatrin Lukanova; Tone Bjørge; Hanno Ulmer; Jonas Manjer; Martin Almquist; Hans Concin; Anders Engeland; Göran Hallmans; Gabriele Nagel; Steinar Tretli; Marit B. Veierød; Håkan Jonsson; Pär Stattin; for the Metabolic Syndrome Cancer Project (Me-Can) Group
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 351 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND The authors tested the hypothesis that the metabolic syndrome (≥3 of the following components: high blood pressure, increased waist circumference, hypertriglyceridemia, low levels of high‐density lipoprotein cholesterol, or diabetes/hyperglycemia) is a risk factor for col
## Abstract Obesity and its associated metabolic syndrome (MetS) are recognized risk factors for breast cancer. The molecular basis for this association remains largely unknown. Adipokines, in particular leptin and adiponectin, are thought to form part of the mechanism linking obesity with cancer t
## Abstract An individually matched case‐control study of testis cancer in 131 men under age 40 was counducted to investigate antecedent risk factors including events during prenatal life. Ten patients were born with an undescended testis compared to only two controls (p = 0.02), a previously repor